"Prospective Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
| Descriptor ID |
D011446
|
| MeSH Number(s) |
E05.318.760.500.750.625 N05.715.360.775.175.250.630 N06.850.520.450.500.750.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prospective Studies".
Below are MeSH descriptors whose meaning is more specific than "Prospective Studies".
This graph shows the total number of publications written about "Prospective Studies" by people in this website by year, and whether "Prospective Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 41 | 41 |
| 1996 | 0 | 33 | 33 |
| 1997 | 0 | 57 | 57 |
| 1998 | 0 | 53 | 53 |
| 1999 | 0 | 60 | 60 |
| 2000 | 0 | 67 | 67 |
| 2001 | 0 | 70 | 70 |
| 2002 | 0 | 75 | 75 |
| 2003 | 0 | 90 | 90 |
| 2004 | 0 | 94 | 94 |
| 2005 | 0 | 91 | 91 |
| 2006 | 0 | 93 | 93 |
| 2007 | 0 | 91 | 91 |
| 2008 | 0 | 102 | 102 |
| 2009 | 0 | 98 | 98 |
| 2010 | 0 | 108 | 108 |
| 2011 | 0 | 141 | 141 |
| 2012 | 0 | 147 | 147 |
| 2013 | 0 | 197 | 197 |
| 2014 | 0 | 211 | 211 |
| 2015 | 0 | 229 | 229 |
| 2016 | 0 | 258 | 258 |
| 2017 | 0 | 290 | 290 |
| 2018 | 0 | 285 | 285 |
| 2019 | 0 | 301 | 301 |
| 2020 | 0 | 296 | 296 |
| 2021 | 0 | 245 | 245 |
| 2022 | 0 | 248 | 248 |
| 2023 | 0 | 209 | 209 |
| 2024 | 0 | 227 | 227 |
| 2025 | 0 | 136 | 136 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prospective Studies" by people in Profiles.
-
Associations of genetic risk and modifiable lifestyle factors with comorbid psoriasis and Crohns disease. Clin Exp Dermatol. 2025 Oct 27; 50(11):2232-2239.
-
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenstr?m macroglobulinemia. Blood Adv. 2025 Oct 14; 9(19):4842-4847.
-
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
-
Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 2025 Oct; 13(10):e1681-e1690.
-
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenstr?m macroglobulinemia. Blood Adv. 2025 Sep 23; 9(18):4568-4579.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort study. Lancet. 2025 Oct 04; 406(10511):1497-1507.
-
Serotonergic receptor binding in the brainstem in the Sudden Infant Death Syndrome in a high-risk population. PLoS One. 2025; 20(9):e0330940.
-
Identifying bio-behavioural signatures of persistent opioid use risk in trauma injury patients: a protocol for a prospective cohort study. BMJ Open. 2025 Sep 05; 15(9):e103053.
-
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA. Cancer Discov. 2025 Sep 04; 15(9):1794-1802.